High-tech tablet manufacturing opened in Mordovia

The opening of a new high-tech tablet shop with a production capacity of one billion tablets per year took place on December 17 at the Saransk Biochemist plant, part of the Promomed Group of Companies, the press service of the head of the republic reports.

More than 1.8 billion rubles of investments have been invested in the project, which is important not only for the region, but also for the country as a whole. The new workshop will produce strategically important medicines that are important for the technological sovereignty of the country and reduce dependence on foreign supplies of pharmaceutical products.

"The symbolic start button of the workshop was pressed by the Deputy Minister of Health Of Russia Sergey Glagolev, Chairman of the Committee The Federation Council for Defense and Security Viktor Bondarev, First Deputy Chairman of the Health CommitteeFedot Tumusov, Head of the State Duma of Mordovia Artyom Zdunov and Peter Bely, Chairman of the Board of Directors of Promomed Group," the message says.

Bely spoke about the development of the industrial giant as a whole and the specifics of the new production. Production buildings, workshops and facilities for the fermentation of synthetically active pharmaceutical substances, injection production, a full production cycle of low-molecular-weight heparin substances are located on 28 hectares, and production sites for the manufacture of chemical and oncological substances are being equipped. The construction of the largest and most environmentally friendly sewage treatment plant complex in the country is coming to an end.

"Promomed Group's new production facility is one of the most modern in Europe. Vacuum transfer technologies are used here instead of human labor. It is equipped with the most modern technologies, including for the manufacture of multilayer and composite tablets produced in conditions of photosensitivity and zero humidity," the report says.

Antiviral, nonsteroidal anti-inflammatory, and heparoprotective drugs will be released from the workshop lines. In the near future, the production of drugs in the form of sachets (in sachets) will be launched. The conditions and technological parameters of the release are controlled by means of monitoring, data collection, dispatching and timely management. This will allow us to produce the highest quality products on all lines.

As noted by the Minister of Health of the Russian Federation Mikhail Murashko, the pharmaceutical industry responded promptly to the challenges of COVID-19 and promptly launched the production of drugs that have saved thousands of lives of our citizens. "I would like to express my confidence that the inclusion of a new production site in the ranks of Russian pharmaceutical manufacturers will allow us to become more confident, this will be the key to the development of healthcare and the pharmaceutical industry in Russia as a whole," the minister's words are quoted in the message.

State Duma deputy Tumusov noted that the new production facility "ensures not only the technological superiority of the enterprise over others, but also our country's superiority over other pharmaceutical manufacturing countries."

"By opening such production facilities, we are proving to the whole world that Russia is capable of being completely technologically independent. We can produce the necessary equipment, train people, and go all the way to protect intellectual property. We are dealing with the safety and lives of people, and we act as a single team. We are already thinking about the next stage of production, new investments and markets," the press service quoted Zdunov as saying.

The Russian Deputy Minister of Health said that the new workshop "actually digitizes the production of medicines, takes them to a fundamentally new level, makes the mechanism for creating solid dosage forms controllable, scalable and allows you to adapt to changing market conditions and healthcare needs in a short time." "This is not only a victory, but also a tremendous proof of our strength in response to external challenges," Glagolev stressed.

A source:  ria.ru

Sources

1. https://ria.ru/20221217/medproizvodstvo-1839441107.html